Legal Updates
Jaw Damage Linked to Bisphosphonates
Monday, November 10, 2008
For several years medications prescribed to combat osteoporosis have been linked to a widely publicized condition in which jawbone tissue dies. Dr. Thomas B. Dodson explains: “Bisphosphonate-related osteonecrosis of the jaw is a mouthful.” His expertise is oral and maxillofacial surgery at Massachusetts General Hospital. He’s an expert on, let’s…
Avandia & Fosamax Linked to Adverse Events
Monday, April 28, 2008
New information has been released linking both Avandia and Fosamax, to adverse events. One study found that long-term use of Avandia increases risk for bone fractures. Additionally, a second study illustrates that Fosamax, which is used to prevent fractures in women with osteoporosis, may be associated with a higher risk…
Fosamax Associated to Unusual Femur Fractures
Monday, March 24, 2008
According to recent data, the safety of Fosamax is once again being questioned. Researchers report that long-term use of Fosamax is linked with unusual fractures of the thighbone. Fosamax is a bisphosphonate, a class of drugs used to increase bone mass and reduce the risk of fracture in those who…
Osteoporosis Drugs Causing Severe Bone Deterioration In Patients
Tuesday, February 05, 2008
Osteoporosis drugs, prescribed to thwart bone loss, are causing jawbones in women to deteriorate, a new study says. The University of British Columbia’s study states that these drugs triple the risk of bone necrosis, which leads to disfigurement and incapacitating pain. But Fosamax is a bisphosphonate, which is a class…
Bone-Strengthening Drugs May Be Overprescribed
Friday, January 18, 2008
Drug companies exaggerate the benefits and downplay the risks of prescribing bone-strengthening drugs for women whose bones are weakened but who do not have osteoporosis, a new report claims. Drugs such as raloxifene, alendronate and risedronate do reduce the risk of fractures of women with osteoporosis, according to the article…
Fosamax Users Seek Class-Action Status
Friday, November 30, 2007
Lawyers for Fosamax users who believe their jaws were damaged by the osteoporosis drug on Friday asked a federal judge to order Merck & Co. to provide a dental monitoring program for the drug's users. The lawyers made the suggestion to U.S. District Judge John F. Keenan as they argued…
